Gut microbiome influences efficacy of PD-1–based immunotherapy against epithelial tumorsBertrand Routy, Laurence Zitvogel, María Paula Roberti et al.|Science|2017Cited by 5.4k
Cross-reactivity between tumor MHC class I–restricted antigens and an enterococcal bacteriophageAurélie Fluckiger, Vincent Cattoir, Romain Daillère et al.|Science|2020Cited by 382
Antibiotics are associated with decreased progression-free survival of advanced melanoma patients treated with immune checkpoint inhibitorsArielle Elkrief, Bertrand Routy, Layal El Raichani et al.|OncoImmunology|2019Cited by 207
A phase I trial of NK-92 cells for refractory hematological malignancies relapsing after autologous hematopoietic cell transplantation shows safety and evidence of efficacyBrent A. Williams, Armand Keating, Arjun Law et al.|Oncotarget|2017Cited by 187
The Bacterium Akkermansia muciniphila: A Sentinel for Gut Permeability and Its Relevance to HIV-Related InflammationJing Ouyang, Jean‐Pierre Routy, John Lin et al.|Frontiers in Immunology|2020Cited by 126